Related Experiment Video
Updated: Mar 2, 2026
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site -
Jens Müller von der Grün1, Aykut Tahtali2, Shahram Ghanaati3
1Department of Radiation Oncology, University Hospital, Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60590, Frankfurt, Germany.
Background And Purpose:
This review aims to provide a comprehensive overview of the literature and elucidate open questions for future clinical trials concerning diagnostics and treatment modalities for cervical cancer of unknown primary (CUP).
Methods:
A literature search for head and neck CUP was performed with focus on diagnostics and therapies as well as molecular markers.
Results:
High level evidence on CUP is limited. However, it seems that a consensus exists regarding the optimal diagnostic procedures. The correct implementation of biomarkers for patient stratification and treatment remains unclear. An even greater dispute dominates about the ideal treatment with publications ranging from sole surgery to surgery with postoperative bilateral radiotherapy with inclusion of the mucosa and concomitant chemotherapy.
Conclusions:
Cervical CUP represents a very heterogeneous malignant disease. On this account many aspects concerning treatment optimization remain unclear, despite a considerable number of publications in the past. Future research in form of prospective randomized trials is needed in order to better define patient stratification criteria and enable tailored treatment.
Insights
Cervical cancer of unknown primary (CUP) is a complex disease with unclear optimal treatment. Future trials are needed to define patient stratification and tailor therapies for better outcomes.
Area of Science:
- Oncology
- Head and Neck Surgery
- Molecular Diagnostics
Background:
- Cervical cancer of unknown primary (CUP) presents diagnostic and therapeutic challenges.
- High-level evidence for CUP management is limited, necessitating further research.
Purpose of the Study:
- To comprehensively review the literature on diagnostics and treatment for cervical CUP.
- To identify and elucidate open questions for future clinical trials in CUP management.
Main Methods:
- Literature search focused on head and neck CUP diagnostics, therapies, and molecular markers.
- Review of existing publications to synthesize current knowledge and identify gaps.
Main Results:
- Consensus exists on optimal diagnostic procedures for CUP.
- Biomarker implementation for patient stratification and treatment remains unclear.
- Significant debate surrounds the ideal treatment approach, ranging from surgery alone to multimodal therapy.
Conclusions:
- Cervical CUP is a heterogeneous malignancy with many unresolved treatment optimization aspects.
- Prospective randomized trials are essential to define patient stratification criteria.
- Tailored treatment strategies are needed for improved outcomes in cervical CUP.
